1. Antithrombotics in Arterial Disease: Focus on Coronary Disease

3. Program Goals

4. Antiplatelet Therapy Improved Outcomes

5. Advances in Antiplatelet Therapy

6. Anticoagulation in ACS: Warfarin

7. Anticoagulation in ACS: NOACs

8. ATLAS-2 Reduction in Mortality

9. NOACs Plus Antiplatelet Agents Lessons Learned

10. WOEST and ISAR-TRIPLE

11. PIONEER AF-PCI Trial Design

12. PIONEER AF-PCI Results

13. COMPASS Trial Design

14. COMPASS Trial Design (cont)

15. COMPASS Pantoprazole-Based Randomization

16. COMPASS Trial Design (cont)

17. COMPASS Inclusion Criteria

18. COMPASS Inclusion Criteria (cont)

19. COMPASS CABG

20. COMPASS MIND

21. NAVIGATE ESUS Trial Design

22. COMPASS PPI Substudy

23. Summary

24. Abbreviations

25. Abbreviations (cont)